AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
ERYTHROMYCIN ESTOLATE in Malawi
8 products registered with PMRA — 0 active, 8 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ERYCACH_250 250MG TABLET TABLET | PMPB/PL477/19 | — | expired | 31 Mar 2024 |
| ERYCACH 125MG/5ML SUSPENSION SUSPENSION | PMPB/PL477/18 | — | expired | 31 Mar 2024 |
| ERYTHROMYCIN_ESTOLATE 250MG CAPSULE CAPSULE | PMPB/PL401/20 | — | expired | 30 Jun 2016 |
| ERYTHROMYCIN_ESTOLATE 250MG CAPSULE CAPSULE | PMPB/PL275/20 | — | expired | 30 Jun 2012 |
| ERYCIN 125ML/5ML ORAL SUSPENSION ORAL SUSPENSION | PMPB/PL167/135 | — | expired | 30 Jun 2011 |
| ESTOMED-125 125MG/5ML SUSPENSION SUSPENSION | PMPB/PL292/24 | — | expired | 30 Jun 2010 |
| BETAMYCIN 125MG/5ML SUSPENSION SUSPENSION | PMPB/PL4/37 | — | expired | 30 Nov 2004 |
| ERYC 125MG/5ML SYRUP SYRUP | PMPB/PL157/17 | — | expired | 28 Feb 2003 |
ERYTHROMYCIN ESTOLATE — PMRA Registration Details
PMRA (Malawi) has 8 registered products containing ERYTHROMYCIN ESTOLATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track ERYTHROMYCIN ESTOLATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.